[ad_1] SAN DIEGO, Nov. 10, 2025 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that the Avantor class action lawsuit – captioned Building Trades Pension Fund of Western Pennsylvania v. Avantor, Inc., No. 25-cv-06187 […]
Tag: Robbins Geller Rudman & Dowd LLP
Robbins Geller Rudman & Dowd LLP Announces that CarMax, Inc. (KMX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
[ad_1] SAN DIEGO, Nov. 8, 2025 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of CarMax, Inc. (NYSE: KMX) publicly traded securities between June 20, 2025 and September 24, 2025, […]
MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
[ad_1] SAN DIEGO, Nov. 7, 2025 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that the MoonLake class action lawsuit – captioned Peters v. MoonLake Immunotherapeutics, No. 25-cv-08612 (S.D.N.Y.) – […]
Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm
[ad_1] SAN DIEGO, Nov. 7, 2025 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Soleno Therapeutics, Inc. (NASDAQ: SLNO) focused on whether Soleno and certain […]
Synopsys, Inc. Investors with Substantial Losses Have Opportunity to Lead the Synopsys Class Action Lawsuit
[ad_1] SAN DIEGO, Oct. 31, 2025 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that the Synopsys class action lawsuit – captioned Kim v. Synopsys, Inc., No. 25-cv-09410 (N.D. Cal.) – charges Synopsys, Inc. (NASDAQ: SNPS) […]
